Squarepoint’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-81,999
| Closed | -$14.8M | – | 2980 |
|
2025
Q1 | $14.8M | Buy |
81,999
+72,440
| +758% | +$13.1M | 0.02% | 442 |
|
2024
Q4 | $1.5M | Sell |
9,559
-6,147
| -39% | -$963K | ﹤0.01% | 1309 |
|
2024
Q3 | $2.86M | Buy |
15,706
+13,298
| +552% | +$2.42M | ﹤0.01% | 978 |
|
2024
Q2 | $442K | Buy |
+2,408
| New | +$442K | ﹤0.01% | 1788 |
|
2024
Q1 | – | Sell |
-3,709
| Closed | -$460K | – | 2687 |
|
2023
Q4 | $460K | Buy |
+3,709
| New | +$460K | ﹤0.01% | 1747 |
|
2022
Q4 | – | Sell |
-8,320
| Closed | -$580K | – | 2475 |
|
2022
Q3 | $580K | Buy |
+8,320
| New | +$580K | ﹤0.01% | 1346 |
|
2022
Q1 | – | Sell |
-21,794
| Closed | -$1.52M | – | 2555 |
|
2021
Q4 | $1.52M | Buy |
21,794
+8,909
| +69% | +$623K | ﹤0.01% | 1001 |
|
2021
Q3 | $673K | Buy |
12,885
+8,384
| +186% | +$438K | ﹤0.01% | 1252 |
|
2021
Q2 | $306K | Buy |
+4,501
| New | +$306K | ﹤0.01% | 1947 |
|
2020
Q3 | – | Sell |
-5,758
| Closed | -$238K | – | 2519 |
|
2020
Q2 | $238K | Buy |
+5,758
| New | +$238K | ﹤0.01% | 1678 |
|
2020
Q1 | – | Sell |
-11,762
| Closed | -$651K | – | 2167 |
|
2019
Q4 | $651K | Sell |
11,762
-20,147
| -63% | -$1.12M | ﹤0.01% | 1574 |
|
2019
Q3 | $1.11M | Sell |
31,909
-7,519
| -19% | -$261K | 0.01% | 1135 |
|
2019
Q2 | $1.59M | Buy |
39,428
+32,777
| +493% | +$1.32M | 0.02% | 965 |
|
2019
Q1 | $219K | Buy |
+6,651
| New | +$219K | ﹤0.01% | 1861 |
|
2018
Q1 | – | Sell |
-10,800
| Closed | -$114K | – | 1923 |
|
2017
Q4 | $114K | Buy |
+10,800
| New | +$114K | ﹤0.01% | 1922 |
|